Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Xenetic Biosciences, Inc. - Common Stock (NQ:XBIO)

2.700 -0.010 (-0.37%)

Streaming Delayed Price Updated: 1:21 PM EDT, Jul 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	38,110
Open	2.740
Bid (Size)	2.650 (200)
Ask (Size)	2.900 (100)
Prev. Close	2.710
Today's Range	2.690 - 2.850
52wk Range	1.900 - 13.93
Shares Outstanding	2,291,056
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination With Anti-CD19 CAR T Cells in Large B-Cell Lymphoma

June 04, 2026

Via ACCESS Newswire

Xenetic Biosciences Showcases Compelling ASCO 2026 Data Demonstrating DNase I Significantly Enhances CAR-T Cell Persistence, Tumor Control, and Survival

June 01, 2026

Via ACCESS Newswire

Performance

YTD	+25.6%	+25.6%
1 Month	-12.6%	-12.6%
3 Month	-11.5%	-11.5%
6 Month	+24.6%	+24.6%
1 Year	-31.3%	-31.3%

More News

Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform

May 13, 2026

Via ACCESS Newswire

Xenetic Biosciences, Inc. Announces Abstract Acceptance for Presentation at the 2026 ASCO Annual Meeting

April 22, 2026

Via ACCESS Newswire

Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results

March 13, 2026

Via ACCESS Newswire

Why Did UPB Stock Pop 20% In Pre-Market Today? ↗

February 11, 2026

Via Stocktwits

Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting

December 11, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 19, 2025

Via Benzinga

Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform

November 19, 2025

Via ACCESS Newswire

Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results

November 13, 2025

Via ACCESS Newswire

Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges ↗

October 10, 2025

Via Benzinga

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

October 10, 2025

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 10, 2025

Via Benzinga

Which stocks are experiencing notable movement on Friday? ↗

October 10, 2025

Via Chartmill

Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock

October 10, 2025

Via ACCESS Newswire

4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings ↗

October 09, 2025

Via Benzinga

Which stocks are moving before the opening bell on Thursday? ↗

October 09, 2025

Via Chartmill

Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗

October 09, 2025

Via Benzinga

MAGA Stocks Undercard: MYSE, XBIO, ATON, ACXP, RDZN – Innovators Driving Next Tech, Blockchain, AI Wave – More Stocks Inside

October 08, 2025

Via AB Newswire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 08, 2025

Via Benzinga

Nasdaq Gains 150 Points; US Mortgage Applications Decline ↗

October 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 08, 2025

Via Benzinga

Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗

October 08, 2025

Via Benzinga

Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results

August 13, 2025

Via ACCESS Newswire

Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Large B Cell Lymphoma

July 30, 2025

Via ACCESS Newswire

Frequently Asked Questions

Is Xenetic Biosciences, Inc. - Common Stock publicly traded?

Yes, Xenetic Biosciences, Inc. - Common Stock is publicly traded.

What exchange does Xenetic Biosciences, Inc. - Common Stock trade on?

Xenetic Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Xenetic Biosciences, Inc. - Common Stock?

The ticker symbol for Xenetic Biosciences, Inc. - Common Stock is XBIO on the Nasdaq Stock Market

What is the current price of Xenetic Biosciences, Inc. - Common Stock?

The current price of Xenetic Biosciences, Inc. - Common Stock is 2.700

When was Xenetic Biosciences, Inc. - Common Stock last traded?

The last trade of Xenetic Biosciences, Inc. - Common Stock was at 07/09/26 01:21 PM ET

What is the market capitalization of Xenetic Biosciences, Inc. - Common Stock?

The market capitalization of Xenetic Biosciences, Inc. - Common Stock is 6.19M

How many shares of Xenetic Biosciences, Inc. - Common Stock are outstanding?

Xenetic Biosciences, Inc. - Common Stock has 6M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.